首页> 中文期刊> 《中国科学》 >Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19

Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19

         

摘要

Dear editor,Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-Co V-2) is a global pandemic leading to a broad spectrum of clinical manifestations, from asymptomatic or mild-to-moderate symptoms, to severe illness, and even death. Accumulating evidence suggests that old age and underlying comorbidities。

著录项

  • 来源
    《中国科学》 |2022年第12期|2560-2563|共4页
  • 作者单位

    Prenatal Diagnosis Center;

    Department of Clinical Laboratory;

    Changning Maternity and Infant Health Hospital;

    East China Normal University;

    Shanghai 200051;

    China;

    Bio-X Institutes;

    Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders(Ministry of Education);

    Shanghai Jiao Tong University;

    Shanghai 200030;

    China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肺炎;
  • 关键词

    clinical; acute; respiratory;

相似文献

  • 中文文献
  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号